参考文献/References:
[1]Boden WE,Probstfield JL,Anderson T,et al.Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy[J].N Engl J Med,2011,365(24):2255-2267.
[2]Kasubuchi M,Hasegawa S,Hiramatsu T,et al.Dietary gut microbial metabolites,short-chain fatty acids,and host metabolic regulation[J].Nutrients,2015,7(4):2839-2849.
[3]Nagatomo Y,Tang WH.Intersections between microbiome and heart failure:Revisiting the gut hypothesis[J].J Card Fai,2015,21(12):973-980.
[4]Brandao RL,Castro IM,Bambirra EA,et al.Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae[J].Appl Environ Microbiol,1998,64(2):564-568.
[5]Guillot JF.Probiotic feed additives[J].J Vet Pharmacol Ther,2003(26):52-55.
[6]Isolauri E,Sutas Y,Kankaanpaa P,et al.Probiotics:Effects on immunity[J].Am J Clin Nutr,2001,73(2 Suppl):444S-450S.
[7]Thushara RM,Gangadaran S,Solati Z,et al.Cardiovascular benefifits of probiotics:a review of experimental and clinical studies[J].Food Funct,2016,7(2):632-642.
[8]Hill C,Guarner F,Reid G,et al.Expert consensus document:The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic[J].Nat Rev Gastroenterol Hepatol,2014,11(8):506-514.
[9]Schoster A,Kokotovic B,Permin A,et al.In Vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains[J].Anaerobe,2013(20):36-41.
[10]Chingwaru W,Vidmar J.Potential of Zimbabwean commercial probiotic products and strains of Lactobacillus plantarum as prophylaxis and therapy against diarrhoea caused by Escherichia coli in children[J].Asian Pac J Trop Med,2017,10(1):57-63.
[11]Sikorska H,Smoragiewicz W.Role of probiotics in the prevention and treatment of ethicillin-resistant Staphylococcus aureus infections[J].Int J Antimicrob Agents,2013,42(6):475-481.
[12]Li P,Gu Q.Complete genome sequence of Lactobacillus plantarum LZ95,a potential probiotic strain producing bacteriocins and B-group vitamin riboflavin[J].J Biotechnol,2016(229):1-2.
[13]Nova E,Warnberg J,Gomez-Martinez S,et al.Immunodulatory effects of probiotics in different stages of life[J].Br J Nutr,2007,98(Suppl 1):S90-S95.
[14]Mann GV.A factor in yogurt which lowers cholesteremia in man[J].Atherosclerosis,1977,26(3):335-340.
[15]Nguyen TD,Kang JH,Lee MS.Characterization of lactobacillus plantarum PH04,a potential probiotic bacterium with cholesterol-lowering effects[J].Int J Food Microbiol,2007,113(3):358-361.
[16]Sharma S,Kurpad AV,Puri S.Potential of probiotics in hypercholesterolemia:A meta-analysis[J].Indian J Public Health,2016,60(4):280-286.
[17]Ito M,Kusuhara S,Yokoi W,et al.Streptococcus thermophilus fermented milk reduces serum MDA-LDL and blood pressure in healthy and mildly hypercholesterolaemic adults[J].Benefcial Microbes,2017,8(2):171-178.
[18]Costabile A,Buttarazzi I,Kolida S,et al.An in vivo assessment of the cholesterol-lowering efficacy of Lactobacillus plantarum ECGC 13110402 in normal to mildly hypercholesterolaemic adults[J].PLoS One,2017,12(12):e0187964.
[19]Mariush TM,Ismail SH.Clinical Effects of Probiotic Supplementation on Type-2 Diabetic Iraqi Patients Associated with Dyslipidemia[J].J Phys Pharm Adv,2013,3(9):239-246.
[20]解傲,袁杰利.双歧杆菌降胆固醇的作用机制[J].中国微生态学志,2014,26(4):493-495.
[21]Lewis SJ,Burmeister S.A double-blind placebo-controlled study of the effects of lactobacillus acidophilus on plasma lipids[J].Eur J Clin Nutr,2005,59(6):776-780.
[22]Simons LA,Amansec SG,Conway P.Effect of lactobacillus fermentum on serum lipids in subjects with elevated serum cholesterol[J].Nutr Metab Cardiovas,2006,16(8):531-535.
[23]Guariguata L,Whiting DR,Hambleton I,et al.Global estimates of diabetes prevalence for 2013 and projections for 2035[J].Diabetes Res Clin Pract,2014,103(2):137-149.
[24]Koutnikova H,Genser B,Monteiro-Sepulveda M,et al.Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables:a systematic review and meta-analysis of randomised controlled trials[J].BMJ Open,2019,9(3):e017995.
[25]Ryan PM,Ross RP,Fitzgerald GF,et al.Functional food addressing heart health:Do we have to target the gut microbiota[J].Curr Opin Clin Nutr Metab Care,2015,18(6):566-571.
[26]Sun J,Buys N.Effects of probiotics consumption on lowering lipids and CVD risk factors:A systematic review and meta-analysis of randomized controlled trials[J].Ann Med,2015,47(6):430-440.
[27]Hua LM.Type 2 diabetes and probiotics, prebiotics and synbiotics:a meta-analysis[J].Chin J Microecol,2016(28):1257-1268.
[28]Li C,Li X,Han H,et al.Effect of probiotics on metabolic profiles in type 2 diabetes mellitus: a meta-analysis of randomized,controlled trials[J].Medicine,2016,95(26):e4088.
[29]Bayat A,Azizi-Soleiman F,Heidari-Beni M,et al.Effect of cucurbita ficifolia and probiotic yogurt consumption on blood glucose,lipid profile,and inflammatory marker in type 2 diabetes[J].Int J Prev Med,2016(7):30.
[30]Hendijani F,Akbari V.Probiotic supplementation for management of cardiovascular risk factors in adults with type Ⅱdiabetes:A systematic review and meta-analysis[J].Clin Nutr,2018,37(2):532-541.
[31]Ostadrahimi A,Taghizadeh A,Mobasseri M,et al.Effect of probiotic fermented milk(kefir)on glycemic control and lipid profile in type 2 diabetic patients:a randomized double -blind placebo- controlled clinical trial[J].Iran J Public Health,2015,44(2):228-237．
[32]Hsieh MC,Tsai WH,Jheng YP,et al.The benefcial efects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus:a randomized,double blinded,placebo-controlled trial[J].Scientific Reports,2018,8(1):16791.
相似文献/References:
[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in
Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(18):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Journal of Medical Information,2018,31(18):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的
相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Journal of Medical Information,2018,31(18):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[4]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Journal of Medical Information,2018,31(18):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[5]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Journal of Medical Information,2018,31(18):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[6]郭云飞,王亚柱,刘 超,等.血浆致动脉硬化指数与冠心病合并2型糖尿病的相关性分析[J].医学信息,2022,35(09):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
GUO Yun-fei,WANG Ya-zhu,LIU Chao,et al.Correlation Between Plasma Arteriosclerosis Index and Coronary Heart Disease Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2022,35(18):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
[7]徐晨曦.达格列净联合DPP-4抑制剂与二甲双胍对血糖控制不佳2型糖尿病患者血糖及脂代谢的影响[J].医学信息,2022,35(09):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
XU Chen-xi.Effects of Daglitazone Combined with DPP-4 Inhibitor and Metformin on Blood Glucose and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus with Poor Glycemic Control[J].Journal of Medical Information,2022,35(18):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
[8]桑巧芳,薛赠燕,谢军培,等.血液滤过联合益生菌治疗重症急性胰腺炎患者的效果[J].医学信息,2022,35(10):149.[doi:10.3969/j.issn.1006-1959.2022.10.037]
SANG Qiao-fang,XUE Zeng-yan,XIE Jun-pei,et al.Effect of Hemofiltration Combined with Probiotics on Patients with Severe Acute Pancreatitis[J].Journal of Medical Information,2022,35(18):149.[doi:10.3969/j.issn.1006-1959.2022.10.037]
[9]余 佳.早期胰岛素强化治疗对初诊2型糖尿病患者血糖控制效果及颈动脉粥样硬化进展的影响[J].医学信息,2022,35(10):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
YU Jia.Effect of Early Intensive Insulin Therapy on Blood Glucose Control and Progression of Carotid Atherosclerosis in Newly Diagnosed Type 2 Diabetic Mellitus Patients[J].Journal of Medical Information,2022,35(18):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
[10]张剑君.2型糖尿病参与血管衰老的机制[J].医学信息,2022,35(11):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
ZHANG Jian-jun.The Mechanism of Type 2 Diabetes Mellitus in Vascular Aging[J].Journal of Medical Information,2022,35(18):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]